Saved in:
| Main Authors: | Rudolph, Kara E., Williams, Nicholas T., Diaz, Ivan, Forrest, Sarah, Hoffman, Katherine L., Samples, Hillary, Olfson, Mark, Doan, Lisa, Cerda, Magdalena, Ross, Rachael |
|---|---|
| Format: | Preprint |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2404.11802 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Completeness and quality of comprehensive managed care data compared with fee‐for‐service data in national Medicaid claims from 2001 to 2019
by: Hillary Samples, et al.
Published: (2025)
by: Hillary Samples, et al.
Published: (2025)
Identifying Extended‐Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data
by: Rachael K. Ross, et al.
Published: (2025)
by: Rachael K. Ross, et al.
Published: (2025)
Two-Step Targeted Minimum-Loss Based Estimation for Non-Negative Two-Part Outcomes
by: Williams, Nicholas T., et al.
Published: (2024)
by: Williams, Nicholas T., et al.
Published: (2024)
A drug classification pipeline for Medicaid claims using RxNorm
by: Williams, Nicholas, et al.
Published: (2024)
by: Williams, Nicholas, et al.
Published: (2024)
Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022
by: Rachael K. Ross, et al.
Published: (2024)
by: Rachael K. Ross, et al.
Published: (2024)
Medicaid managed care restrictions on medications for the treatment of opioid use disorder
by: Maureen T. Stewart, et al.
Published: (2024)
by: Maureen T. Stewart, et al.
Published: (2024)
Studying continuous, time-varying, and/or complex exposures using longitudinal modified treatment policies
by: Hoffman, Katherine L., et al.
Published: (2023)
by: Hoffman, Katherine L., et al.
Published: (2023)
Learning Optimal Dynamic Treatment Regimes from Longitudinal Data
by: Williams, Nicholas T., et al.
Published: (2024)
by: Williams, Nicholas T., et al.
Published: (2024)
From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder
by: Jeremy Weleff, et al.
Published: (2024)
by: Jeremy Weleff, et al.
Published: (2024)
Identification and estimation of mediational effects of longitudinal modified treatment policies
by: Gilbert, Brian, et al.
Published: (2024)
by: Gilbert, Brian, et al.
Published: (2024)
Nonparametric estimation of an optimal treatment rule with fused randomized trials and missing effect modifiers
by: Williams, Nicholas, et al.
Published: (2025)
by: Williams, Nicholas, et al.
Published: (2025)
Modified treatment policies that depend on the natural history of treatment
by: Díaz, Iván, et al.
Published: (2026)
by: Díaz, Iván, et al.
Published: (2026)
Improving efficiency in transporting average treatment effects
by: Rudolph, Kara E., et al.
Published: (2023)
by: Rudolph, Kara E., et al.
Published: (2023)
The association of pain impact and sleep disruption with opioid withdrawal during opioid‐use disorder treatment
by: Jennifer D. Ellis, et al.
Published: (2024)
by: Jennifer D. Ellis, et al.
Published: (2024)
Things We Do for No Reason™: Withholding opioids among patients with acute pain and opioid use disorder
by: Anna‐Maria South, et al.
Published: (2026)
by: Anna‐Maria South, et al.
Published: (2026)
Editorial for the themed issue: Addressing the dual challenges of opioid use disorder and chronic pain in the context of the opioid crisis
by: Mehmet Sofuoglu, et al.
Published: (2024)
by: Mehmet Sofuoglu, et al.
Published: (2024)
Benchmarking the Transformed Medicaid Statistical Information System Analytic Files for analysis of opioid use disorder treatment
by: Mah Afroze Chughtai, et al.
Published: (2024)
by: Mah Afroze Chughtai, et al.
Published: (2024)
Causal survival analysis under competing risks using longitudinal modified treatment policies
by: Díaz, Iván, et al.
Published: (2022)
by: Díaz, Iván, et al.
Published: (2022)
Who Are We Missing? A Principled Approach to Characterizing the Underrepresented Population
by: Parikh, Harsh, et al.
Published: (2024)
by: Parikh, Harsh, et al.
Published: (2024)
Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder
by: Payel J. Roy, et al.
Published: (2025)
by: Payel J. Roy, et al.
Published: (2025)
Disabled Patients' Experiences of Healthcare Services in a Nationally Representative Sample of U.S. Adults
by: Elizabeth M. Stone, et al.
Published: (2025)
by: Elizabeth M. Stone, et al.
Published: (2025)
The relationship of pain intensity and opioid craving with delayed methadone dose: A preliminary study of individuals with opioid use disorder
by: R. Ross MacLean, et al.
Published: (2024)
by: R. Ross MacLean, et al.
Published: (2024)
Contingency management as a maintenance intervention in the long‐term treatment of substance use disorders
by: Forrest Toegel, et al.
Published: (2024)
by: Forrest Toegel, et al.
Published: (2024)
Longitudinal Generalizations of the Average Treatment Effect on the Treated for Multi-valued and Continuous Treatments
by: Susmann, Herbert, et al.
Published: (2024)
by: Susmann, Herbert, et al.
Published: (2024)
General targeted machine learning for modern causal mediation analysis
by: Liu, Richard, et al.
Published: (2024)
by: Liu, Richard, et al.
Published: (2024)
crumble: A comprehensive framework for modern causal mediation analysis with intermediate confounding
by: Liu, Richard, et al.
Published: (2026)
by: Liu, Richard, et al.
Published: (2026)
Development and evaluation of a machine learning model to predict acute care for opioid use disorder among Medicaid enrollees engaged in a community‐based treatment program
by: Lingshu Xue, et al.
Published: (2025)
by: Lingshu Xue, et al.
Published: (2025)
Effect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsured
by: Kristin M. Primm, et al.
Published: (2024)
by: Kristin M. Primm, et al.
Published: (2024)
Transporting results from a trial to an external target population when trial participation impacts adherence
by: Ross, Rachael K., et al.
Published: (2025)
by: Ross, Rachael K., et al.
Published: (2025)
Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
by: Susan L. Calcaterra, et al.
Published: (2024)
by: Susan L. Calcaterra, et al.
Published: (2024)
Home care for patients with opioid use disorders: A qualitative study of registered nurses' experiences of pain management
by: Mari Asalie Skrenes Jakobsen, et al.
Published: (2024)
by: Mari Asalie Skrenes Jakobsen, et al.
Published: (2024)
What are the sedative effects of different classes of opioids in pain management?
by: Tripdatabase
Published: (2026)
by: Tripdatabase
Published: (2026)
Glial modulators as novel therapeutics for comorbid pain and opioid use disorder
by: Elizabeth K. C. Schwartz, et al.
Published: (2024)
by: Elizabeth K. C. Schwartz, et al.
Published: (2024)
Pharmacists' contributions to the management of opioid use disorder
by: Paul M. Stranges, et al.
Published: (2025)
by: Paul M. Stranges, et al.
Published: (2025)
Chronic opioid use and incident opioid use disorders in survivors of adolescent and young adult cancer after cancer treatment
by: Chun R. Chao, et al.
Published: (2025)
by: Chun R. Chao, et al.
Published: (2025)
FDA issues draft guidance urging non‐opioid pain treatments
by: Alison Knopf
Published: (2025)
by: Alison Knopf
Published: (2025)
Evaluating diversion and treatment policies for opioid use disorder
by: White, Veronica M., et al.
Published: (2023)
by: White, Veronica M., et al.
Published: (2023)
Riesz representers for the rest of us
by: Williams, Nicholas T., et al.
Published: (2025)
by: Williams, Nicholas T., et al.
Published: (2025)
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
by: Abdelrahman G. Tawfik, et al.
Published: (2025)
by: Abdelrahman G. Tawfik, et al.
Published: (2025)
New data on opioid use disorder and risk of overdose in adolescent and young adult disease‐free survivors prescribed opioids after cancer treatment
by: Natalie Moryl, et al.
Published: (2025)
by: Natalie Moryl, et al.
Published: (2025)
Similar Items
-
Completeness and quality of comprehensive managed care data compared with fee‐for‐service data in national Medicaid claims from 2001 to 2019
by: Hillary Samples, et al.
Published: (2025) -
Identifying Extended‐Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data
by: Rachael K. Ross, et al.
Published: (2025) -
Two-Step Targeted Minimum-Loss Based Estimation for Non-Negative Two-Part Outcomes
by: Williams, Nicholas T., et al.
Published: (2024) -
A drug classification pipeline for Medicaid claims using RxNorm
by: Williams, Nicholas, et al.
Published: (2024) -
Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022
by: Rachael K. Ross, et al.
Published: (2024)